Navigation Links
SynapDx Corporation Raises $9 Million in Series A Funding
Date:6/1/2010

WALTHAM, Mass., June 1 /PRNewswire/ -- SynapDx Corp., a new company focused on developing and commercializing diagnostic testing for the early detection of autism, announced the completion of a $9 million Series A financing by Bain Capital Ventures, General Catalyst Partners, and North Bridge Venture Partners.

"Autism has a profound effect on children and their families," said Stanley N. Lapidus, the company's founder, President and Chief Executive Officer.  "The right objective blood-based diagnostic test for autism may help achieve earlier diagnosis, more rapid intervention, and improved outcomes."

About SynapDx Corp.

SynapDx was formed to develop and commercialize blood-based diagnostic tests for the early detection of autism.  SynapDx was founded by Stanley N. Lapidus, an experienced life-sciences entrepreneur and inventor with 31 issued patents.  Mr. Lapidus founded and led Cytyc Corp., EXACT Sciences Corp., and Helicos BioSciences Corp.  Mr. Lapidus' co-founders of SynapDx Corp. include Jeffrey R. Luber, Esq. and Patrick A. Anquetil, PhD.

www.synapdx.com


'/>"/>
SOURCE SynapDx Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010
2. Centene Corporation to Present at Two Upcoming Healthcare Conferences in June
3. West Physics Consulting Signs Exclusive Arrangement With Digirad Corporation
4. AndroScience Corporation Forms Strategic Alliance With Taiwan Based Orient Europharma to Develop Novel Topical Acne Therapeutic
5. Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation
6. Oxford Finance Corporation Facilitates Entry for Reata Pharmaceuticals into Asian Markets
7. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
8. Curexo Technology Corporation Raises $13.2 Million
9. Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing
10. Volcano Corporation Presentation at Bank of America Merrill Lynch Health Care Conference to Be Webcast
11. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):